Overview

ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)

Status:
Unknown status

Trial end date:
2019-06-01

Target enrollment:

Participant gender:

Summary

This clinical trial studies patients treated with the Coroflex ISAR Stent for coronary artery disease in order for the objective of verifying the non-inferiority of results that among patients who were administered DAPT for 3 months compared to patients who were administered DAPT for 6 months, in terms of the efficacy and safety of DAPT.

Phase:

Phase 4

Details

Lead Sponsor:

Ajou University School of Medicine

Collaborator:

B. Braun Korea Co., Ltd.

Treatments:

Aspirin
Clopidogrel
Ticlopidine